# Efficacy and Safety of a Cutaneous Formulation of Gonyautoxin 2/3 (GTX 2/3) for the Treatment of Facial Wrinkles

> **NCT00734786** · PHASE1,PHASE2 · WITHDRAWN · sponsor: **Phytotox SA** · enrollment: 15 (estimated)

## Conditions studied

- Facial Wrinkles

## Interventions

- **OTHER:** Wrinkle cream application

## Key facts

- **NCT ID:** NCT00734786
- **Lead sponsor:** Phytotox SA
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2008-08
- **Primary completion:** 2008-09
- **Final completion:** 2008-09
- **Target enrollment:** 15 (ESTIMATED)
- **Why stopped:** Study cancelled.
- **Last updated:** 2008-08-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00734786

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00734786, "Efficacy and Safety of a Cutaneous Formulation of Gonyautoxin 2/3 (GTX 2/3) for the Treatment of Facial Wrinkles". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00734786. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*